OpenURL Connection Search

Select item for more details and to access through your institution.

PAR(2) and temporomandibular joint inflammation in the rat.
Published in:
2010
By:
- Denadai-Souza A;
- Cenac N;
- Casatti CA;
- Câmara PR;
- Yshii LM;
- Costa SK;
- Vergnolle N;
- Muscará MN;
- Denadai-Souza, A;
- Cenac, N;
- Casatti, C A;
- Câmara, P R de Souza;
- Yshii, L M;
- Costa, S K P;
- Vergnolle, N;
- Muscará, M N
Publication type:
journal article
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway.
Published in:
Nature Medicine, 2001, v. 7, n. 7, p. 821, doi. 10.1038/89945
By:
- Vergnolle, N.;
- Bunnett, N.W.;
- Sharkey, K.A.;
- Brussee, V.;
- Compton, S.J.;
- Grady, E.F.;
- Cirino, G.;
- Gerard, N.;
- Basbaum, A.I.;
- Andrade-Gordon, P.;
- Hollenberg, M.D.;
- Wallace, J.L.
Publication type:
Article
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.
Published in:
Nature Medicine, 2000, v. 6, n. 2, p. 151, doi. 10.1038/72247
By:
- Steinhoff, M.;
- Vergnolle, N.;
- Young, S.H.;
- Tognetto, M.;
- Amadesi, S.;
- Ennes, H.S.;
- Trevisani, M.;
- Hollenberg, M.D.;
- Wallace, J.L.;
- Caughey, G.H.;
- Mitchell, S.E.;
- Williams, L.M.;
- Geppetti, P.;
- Mayer, E.A.;
- Bunnett, N.W.
Publication type:
Article
Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism.
Published in:
2001
By:
- de Garavilla, L;
- Vergnolle, N;
- Young, S H;
- Ennes, H;
- Steinhoff, M;
- Ossovskaya, V S;
- D'Andrea, M R;
- Mayer, E A;
- Wallace, J L;
- Hollenberg, M D;
- Andrade-Gordon, P;
- Bunnett, N W
Publication type:
journal article
Protease-activated receptor 2 contributes to Toxoplasma gondii-mediated gut inflammation.
Published in:
Parasite Immunology, 2017, v. 39, n. 11, p. n/a, doi. 10.1111/pim.12489
By:
- Bonnart, C.;
- Feuillet, G.;
- Vasseur, V.;
- Cenac, N.;
- Vergnolle, N.;
- Blanchard, N.
Publication type:
Article
Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors.
Published in:
Oncogene, 2012, v. 31, n. 6, p. 694, doi. 10.1038/onc.2011.258
By:
- Bertrand, J;
- Despeaux, M;
- Joly, S;
- Bourogaa, E;
- Gallay, N;
- Demur, C;
- Bonnevialle, P;
- Louache, F;
- Maguer-Satta, V;
- Vergnolle, N;
- Payrastre, B;
- Racaud-Sultan, C
Publication type:
Article
Involvement of interleukin-1, prostaglandins and mast cells in rectal distension-induced colonic water secretion in rats.
Published in:
Journal of Physiology, 1998, v. 506, n. 1, p. 245, doi. 10.1111/j.1469-7793.1998.245bx.x
By:
- Eutamene, H.;
- Theodorou, V.;
- Vergnolle, N.;
- Comera, C.;
- Fioramonti, J.;
- Bueno, L.
Publication type:
Article
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin ( AA-5- HT).
Published in:
Neurogastroenterology & Motility, 2017, v. 29, n. 12, p. n/a, doi. 10.1111/nmo.13148
By:
- Bashashati, M.;
- Fichna, J.;
- Piscitelli, F.;
- Capasso, R.;
- Izzo, A. A.;
- Sibaev, A.;
- Timmermans, J.‐P.;
- Cenac, N.;
- Vergnolle, N.;
- Di Marzo, V.;
- Storr, M.
Publication type:
Article
Effects of 1-week sacral nerve stimulation on the rectal intestinal epithelial barrier and neuromuscular transmission in a porcine model.
Published in:
Neurogastroenterology & Motility, 2015, v. 27, n. 1, p. 40, doi. 10.1111/nmo.12465
By:
- Provost, M.;
- Brégeon, J.;
- Aubert, P.;
- Duchalais‐Dassonneville, E.;
- D'Aldebert, E.;
- Vergnolle, N.;
- Neunlist, M.;
- Meurette, G.
Publication type:
Article
Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS.
Published in:
Neurogastroenterology & Motility, 2014, v. 26, n. 11, p. 1539, doi. 10.1111/nmo.12390
By:
- Fichna, J.;
- Sobczak, M.;
- Mokrowiecka, A.;
- Cygankiewicz, A. I.;
- Zakrzewski, P. K.;
- Cenac, N.;
- Sałaga, M.;
- Timmermans, J.‐P.;
- Vergnolle, N.;
- Małecka‐Panas, E.;
- Krajewska, W. M.;
- Storr, M.
Publication type:
Article
Chronic stress mediators act synergistically on colonic nociceptive mouse dorsal root ganglia neurons to increase excitability.
Published in:
Neurogastroenterology & Motility, 2014, v. 26, n. 3, p. 334, doi. 10.1111/nmo.12268
By:
- Ochoa‐Cortes, F.;
- Guerrero–Alba, R.;
- Valdez‐Morales, E. E.;
- Spreadbury, I.;
- Barajas‐Lopez, C.;
- Castro, M.;
- Bertrand, J.;
- Cenac, N.;
- Vergnolle, N.;
- Vanner, S. J.
Publication type:
Article
Inhibition of sensory afferents activation and visceral pain by a brominated algal diterpene.
Published in:
Neurogastroenterology & Motility, 2012, v. 24, n. 7, p. e336, doi. 10.1111/j.1365-2982.2012.01940.x
By:
- Chatter, R.;
- Cenac, N.;
- Roussis, V.;
- Kharrat, R.;
- Vergnolle, N.
Publication type:
Article
Protease-activated receptor-4 (PAR4): a role as inhibitor of visceral pain and hypersensitivity.
Published in:
Neurogastroenterology & Motility, 2009, v. 21, n. 11, p. 1189, doi. 10.1111/j.1365-2982.2009.01310.x
By:
- AUGÉ, C.;
- BALZ-HARA, D.;
- STEINHOFF, M.;
- VERGNOLLE, N.;
- CENAC, N.
Publication type:
Article
Postinflammatory visceral sensitivity and pain mechanisms.
Published in:
Neurogastroenterology & Motility, 2008, v. 20, p. 73, doi. 10.1111/j.1365-2982.2008.01110.x
By:
- Vergnolle, N.
Publication type:
Article
F16357, a novel protease-activated receptor 1 antagonist, improves urodynamic parameters in a rat model of interstitial cystitis.
Published in:
2016
By:
- Monjotin, N;
- Gillespie, J;
- Farrié, M;
- Le Grand, B;
- Junquero, D;
- Vergnolle, N;
- Farrié, M
Publication type:
journal article
Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor.
Published in:
2015
By:
- Gobbetti, T;
- Ducheix, S;
- le Faouder, P;
- Perez, T;
- Riols, F;
- Boue, J;
- Bertrand-Michel, J;
- Dubourdeau, M;
- Guillou, H;
- Perretti, M;
- Vergnolle, N;
- Cenac, N
Publication type:
journal article
Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor.
Published in:
British Journal of Pharmacology, 2015, v. 172, n. 3, p. 910, doi. 10.1111/bph.12957
By:
- Gobbetti, T;
- Ducheix, S;
- Faouder, P;
- Perez, T;
- Riols, F;
- Boue, J;
- Bertrand ‐ Michel, J;
- Dubourdeau, M;
- Guillou, H;
- Perretti, M;
- Vergnolle, N;
- Cenac, N
Publication type:
Article
A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation.
Published in:
2010
By:
- Vergnolle, N;
- Cenac, N;
- Altier, C;
- Cellars, L;
- Chapman, K;
- Zamponi, GW;
- Materazzi, S;
- Nassini, R;
- Liedtke, W;
- Cattaruzza, F;
- Grady, EF;
- Geppetti, P;
- Bunnett, NW;
- Zamponi, G W;
- Grady, E F;
- Bunnett, N W
Publication type:
journal article
Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation.
Published in:
British Journal of Pharmacology, 2007, v. 150, n. 2, p. 176, doi. 10.1038/sj.bjp.0706975
By:
- Asfaha, S.;
- Cenac, N.;
- Houle, S.;
- Altier, C.;
- Papez, M. D.;
- Nguyen, C.;
- Steinhoff, M.;
- Chapman, K.;
- Zamponi, G. W.;
- Vergnolle, N.
Publication type:
Article
The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2).
Published in:
British Journal of Pharmacology, 2006, v. 149, n. 4, p. 374, doi. 10.1038/sj.bjp.0706884
By:
- Dale, C. S.;
- Cenac, N.;
- Britto, L. R. G.;
- Juliano, M. A.;
- Juliano, L.;
- Vergnolle, N.;
- Giorgi, R.
Publication type:
Article
PAR 2 and Temporomandibular Joint Inflammation in the Rat.
Published in:
Journal of Dental Research, 2010, v. 89, n. 10, p. 1123, doi. 10.1177/0022034510375284
By:
- Denadai-Souza, A.;
- Cenac, N.;
- Casatti, C.A.;
- de Souza Câmara, P.R.;
- Yshii, L.M.;
- Costa, S.K.P.;
- Vergnolle, N.;
- Muscará, M.N.
Publication type:
Article
Protease-activated Receptor-2 (par2) in Human Periodontitis.
Published in:
2010
By:
- Holzhausen M;
- Cortelli JR;
- da Silva VA;
- Franco GC;
- Cortelli SC;
- Vergnolle N
Publication type:
Journal Article
Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats.
Published in:
2005
By:
- Holzhausen, M.;
- Spolidorio, L. C.;
- Vergnolle, N.
Publication type:
journal article
Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 3, p. 374, doi. 10.1111/j.1365-2036.2011.04732.x
By:
- Andrews, C. N.;
- Griffiths, T. A.;
- Kaufman, J.;
- Vergnolle, N.;
- Surette, M. G.;
- Rioux, K. P.
Publication type:
Article
Neuroimmune signalling in the gut – mediators linked to disorders?
Published in:
2006
By:
- Vergnolle, N.
Publication type:
Editorial
A novel orally administered trimebutine compound (GIC-1001) is anti-nociceptive and features peripheral opioid agonistic activity and Hydrogen Sulphide-releasing capacity in mice.
Published in:
2016
By:
- Cenac, N.;
- Castro, M.;
- Desormeaux, C.;
- Colin, P.;
- Sie, M.;
- Ranger, M.;
- Vergnolle, N.
Publication type:
journal article

Found: 26

PAR(2) and temporomandibular joint inflammation in the rat.

Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway.

Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.

Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism.

Protease-activated receptor 2 contributes to Toxoplasma gondii-mediated gut inflammation.

Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors.

Involvement of interleukin-1, prostaglandins and mast cells in rectal distension-induced colonic water secretion in rats.

Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin ( AA-5- HT).

Effects of 1-week sacral nerve stimulation on the rectal intestinal epithelial barrier and neuromuscular transmission in a porcine model.

Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS.

Chronic stress mediators act synergistically on colonic nociceptive mouse dorsal root ganglia neurons to increase excitability.

Inhibition of sensory afferents activation and visceral pain by a brominated algal diterpene.

Protease-activated receptor-4 (PAR<sub>4</sub>): a role as inhibitor of visceral pain and hypersensitivity.

Postinflammatory visceral sensitivity and pain mechanisms.

F16357, a novel protease-activated receptor 1 antagonist, improves urodynamic parameters in a rat model of interstitial cystitis.

Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor.

Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A<sub>4</sub> and its receptor.

A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation.

Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation.

The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR<sub>2</sub>).

PAR 2 and Temporomandibular Joint Inflammation in the Rat.

Protease-activated Receptor-2 (par2) in Human Periodontitis.

Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats.

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.

Neuroimmune signalling in the gut – mediators linked to disorders?

A novel orally administered trimebutine compound (GIC-1001) is anti-nociceptive and features peripheral opioid agonistic activity and Hydrogen Sulphide-releasing capacity in mice.